source
- Lisata acquires Marea Therapeutics, securing $225M financing to advance two mid-stage drugsLisata Therapeutics completed a stock-for-stock acquisition of biotech startup Marea Therapeutics. The transaction includes a $225 million financing round led by existing backers such as Forbion,…
- Biotech sector expected to weather Fed rate hike despite higher capital costsThe Federal Reserve raised the federal funds rate by a quarter of a percentage point, a move that traditionally weighs on capital‑intensive industries like biotech. Analysts at BMO Capital Markets…